摘要
Sarittha SOMSUP 医师
儿科医师
Hybrid therapy in clinical practice for accomplishing centenarian longevity
Objectives: The study provides an updated account of genetic factors associated with the extended lifespan and their interactive contributory role with cellular pathways with gene and advance Hybrid therapy in clinical practice including with epigenetics modification for prevention environmental factors which constraints of genetics to either protect or predispose to degenerative diseases.
Introduction: Centenarian longevity is determined by the inherit genes. Some genes promote longevity, including those that encode antioxidant enzymes and heat-shock proteins. Other genes that are associated with serum lipid levels, glycation reaction, repeated inflammation process and immune systems contribute significantly to longevity. Aging is a multifactorial and complex process represented by low energy levels, stress induced loss of homeostasis leading to the risk of diseases and mortality, the functional decline of tissues and organs due to changes in molecular composition and physiology of cells.
Materials / method: The trial in clinical practice to achieve centenarian longevity with gene and advance Hybrid therapy by promoting longevity gene and prevent risk factor that contribute inflammation and degeneration process by gene therapy with stem cell and chorion exosome intramuscular therapy, Metallothionein 1,2,3 (MT1,2,3) intramuscular therapy ,increasing energy level of cells by NAD intravenous infusion, reduce stress of cells,balance homeostasis and deglycation of cell by intravenous multivitamins ,intravenous minerals, deglycating molecules and antioxidation molecules including TMS and biofeedback.
Results: After 6 months of gene and advance Hybrid therapy protocol with stem cell and chorion exosome intramuscular therapy, Metallothionein 1,2,3 (MT1,2,3) intramuscular therapy ,increasing energy level of cells by NAD intravenous infusion, reduce stress of cells,balance homeostasis and deglycation of cell by IV multivitamins ,intravenous minerals, deglycating molecules and antioxidation molecules including TMS and biofeedback for brain plasticity and regeneration.All of cases were improve in quality of life as increase of energy, improve of cognitive function, good mood and decrease sarcopenia.
Conclusion: The gene and advance Hybrid therapy protocol with stem cell and chorion exosome intramuscular therapy, Metallothionein 1,2,3 (MT1,2,3) intramuscular therapy ,increasing energy level of cells by NAD intravenous infusion, reduce stress of cells, balance homeostasis and deglycation of cell by intravenous multivitamins ,intravenous minerals, deglycating molecules and antioxidation molecules including TMS and biofeedback for brain plasticity and regeneration could help to achieve centenarian longevity with good quality of life.
披露 - Sarittha SOMSUP
> 您是否获得了任何资金来支持您关于这个主题的研究?
不是
> 您在这项研究工作中是否获得过任何酬金、报酬或其他形式的补偿?
不是
> 您是否与任何可能与您研究中涉及的药物、材料或器械存在激烈竞争的实体有任何财务关系?
不是
> 您是否拥有或已申请过与您研究中所讨论的仪器、药物或材料相关的任何专利?
不是
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。
Published on 2025年 6月 30日 - Recorded during IMCAS Americas 2025